Inhibition of converting enzyme and thromboxane synthetase in a model of progressive renal disease; effects of enalapril and RS-86328 in the rat.
Rosenkranz
R P
RP
Institute of Pharmacology, Syntex Research, Palo Alto, California 94304.
Hayashi
C M
CM
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004195:Disease Models, Animal; D004656:Enalapril / Q000494:pharmacology*; D007676:Kidney Failure, Chronic / Q000503:physiopathology*; D007678:Kidney Glomerulus / Q000187:drug effects / Q000473:pathology; D008297:Male; D009392:Nephrectomy; D011507:Proteinuria; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors* / Q000494:pharmacology
D000806:Angiotensin-Converting Enzyme Inhibitors; C058301:RS 86328; D004656:Enalapril; D013930:Thromboxane-A Synthase